Categories
Latest Industry Intelligence
The latest eBook by DDW is out now. This 28-page eBook, sponsored by Benchling, examines [...]
Discover the groundbreaking findings from a study on bispecific T cell engagers conducted by The [...]
England will become the first country in Europe to roll out darolutamide (Nubeqa) to patients whose prostate cancer has spread to other parts of the body. The drug works by blocking androgen receptors in cancer cells, which in turn blocks the effect of testosterone that allows the cancer cells to survive and multiply. Studies show […]